Mygin 50 And 100 50 mg & 100 mg Powder for solution for injection or infusion
PDF Leaflet Revision Date: 25 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of invasive candidiasis.
Dosage (summary)
Adults: 100 mg/day for invasive candidiasis; 150 mg/day for oesophageal candidiasis.
Special Populations
- Hepatic impairment
- Renal impairment
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A substrates
- Amphotericin B
Contraindications
- Hypersensitivity to micafungin
- Pregnancy
- Breastfeeding
Common side effects
- Nausea
- Vomiting
- Phlebitis
- Increased liver enzymes
Counselling Points
- Monitor for liver function
- Avoid in pregnancy
- Do not breastfeed while on treatment
Serious warnings
- Risk of liver tumors
- Anaphylactic reactions
- Renal impairment
Important Disclaimer
The Mygin 50 And 100 50 mg & 100 mg Powder for solution for injection or infusion professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
